Get the Stockscreener App
2.235
9.88%
-0.245
After Hours:
2.24
0.005
+0.22%
Absci Corp stock is traded at $2.235, with a volume of 2.80M.
It is down -9.88% in the last 24 hours and down -34.65% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.48
Open:
$2.285
24h Volume:
2.80M
Relative Volume:
0.53
Market Cap:
$294.78M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-2.4032
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
-20.46%
1M Performance:
-34.65%
6M Performance:
-41.34%
1Y Performance:
-57.91%
1-Day Range:
$2.23
$2.36
1-Week Range:
$2.23
$2.86
52-Week Range:
$2.23
$6.72
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.235 | 294.78M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 125.55B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 67.78B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 36.24B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.99B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.77B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
Absci stock touches 52-week low at $2.45 amid market challenges - Investing.com
Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat
Absci to Participate in Upcoming Investor Conferences - MarketScreener
AI Drug Pioneer Absci Takes Center Stage at Two Elite Healthcare Conferences - Stock Titan
Royce & Associates LP Grows Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
HC Wainwright Issues Negative Estimate for Absci Earnings - MarketBeat
Absci Corp’s Earnings Call: Balancing Innovation and Financial Challenges - MSN
KeyBanc maintains Absci stock Overweight rating, $5 target By Investing.com - Investing.com South Africa
KeyBanc maintains Absci stock Overweight rating, $5 target - Investing.com
Platinum Investment Management Ltd. Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Earns Buy Rating from Guggenheim - MarketBeat
Absci (NASDAQ:ABSI) Given "Buy" Rating at HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results - MarketBeat
Absci (NASDAQ:ABSI) Announces Earnings Results - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Nikko Asset Management Americas Inc. Boosts Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
H.C. Wainwright maintains $7 target on Absci stock with Buy rating - Investing.com Australia
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips By Investing.com - Investing.com Australia
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
A Glimpse Into The Expert Outlook On Absci Through 7 Analysts - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga India
Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... By GuruFocus - Investing.com Canada
Absci Corp. Reports 2024 Earnings and Strategic Advances - TipRanks
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips - Investing.com
Absci earnings missed by $0.03, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended December 31Earnings Summary - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Absci shares tumble as Q4 revenue falls short of estimates - Investing.com
Absci Corp SEC 10-K Report - TradingView
Absci reports Q4 EPS (25c), consensus (22c) - TipRanks
AMD Backs Absci With $20M Investment as AI Drug Platform Advances to Clinical Trials - StockTitan
AbSci Corp options imply 16.5% move in share price post-earnings - TipRanks
Earnings Scheduled For March 18, 2025 - Benzinga
Absci (ABSI) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Absci (ABSI) Projected to Post Earnings on Tuesday - Defense World
Rhumbline Advisers Grows Stake in Absci Co. (NASDAQ:ABSI) - Defense World
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD Investment Pledge, Retail's Bullish Despite Pre-Market Dip - MSN
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):